Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.2 (Zeta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.499NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.212NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used